U.S. Generic Injectables Pharmaceutical Contract Manufacturing Market Summary The U.S. generic injectables pharmaceutical contract manufacturing market size was estimated at USD 3.0 billion in 2024 and is projected to grow at a CAGR of 10.8% from 2025 to 2030. Growth in the market can be attributed to the rising frequency of patent expirations for blockbuster drugs, streamlined...